Related Experiment Video
Updated: Sep 30, 2026
Dissecting Cell-Autonomous Function of Fragile X Mental Retardation Protein in an Auditory Circuit by In Ovo Electroporation
Published on: July 6, 2022
Effects of Fragile X syndrome and an FMR1 knockout mouse model on forebrain neuronal cell biology
James D Churchill1, Andrea Beckel-Mitchener, Ivan Jeanne Weiler
1Beckman Institute, University of Illinois, Urbana, Illinois 61801, USA.
Abstract:
The neurological deficits exhibited by patients with Fragile X syndrome (FraX) have been attributed to the absence of the Fragile X Mental Retardation Protein (FMRP), the product of the FMR1 gene, which is nonfunctional in these individuals. While a great deal has been learned about FraX using non-invasive techniques and autopsy tissue from humans, the limited availability of subjects and specimens severely restricts the rate at which such data can be collected and the types of experimental questions posed. In view of these limitations, a transgenic mouse model of FraX has been constructed in which the FMR1 gene is selectively knocked out (KO) [Bakker et al. (1994) Cell 78:23-33]. These mice show molecular, morphological, and behavioral alterations consistent with phenotypes observed in FraX patients, making them good models to study the absence of FMRP expression.
Insights
Fragile X syndrome (FraX) neurological deficits stem from the absence of the Fragile X Mental Retardation Protein (FMRP). A new mouse model with a knocked-out FMR1 gene mimics FraX phenotypes for research.
Area of Science:
- Neurogenetics
- Developmental Neuroscience
- Animal Models
Background:
- Fragile X syndrome (FraX) is characterized by neurological deficits linked to the absence of the Fragile X Mental Retardation Protein (FMRP).
- Human studies are limited by subject and specimen availability, hindering research progress.
- The FMR1 gene produces FMRP, and its nonfunctionality causes FraX.
Purpose of the Study:
- To develop a transgenic mouse model for studying Fragile X syndrome.
- To overcome limitations in human subject research for FraX.
Main Methods:
- Selective knockout of the FMR1 gene in mice to create a transgenic model.
- Comparison of molecular, morphological, and behavioral phenotypes between the mouse model and human FraX patients.
Main Results:
- The FMR1 knockout mouse model exhibits molecular, morphological, and behavioral alterations.
- These alterations are consistent with phenotypes observed in human FraX patients.
- The model effectively replicates the absence of FMRP expression.
Conclusions:
- The FMR1 knockout mouse is a valuable model for investigating the mechanisms underlying Fragile X syndrome.
- This model facilitates research into the consequences of FMRP absence.
- It enables further study of FraX pathophysiology and potential therapeutic targets.
More Related Videos
10:59Generation and Characterization of Human Induced Pluripotent Stem Cell-derived Astrocytes Lacking Fragile X Messenger Ribonucleoprotein
Published on: June 6, 2025
07:43Immunohistochemical Visualization of Hippocampal Neuron Activity After Spatial Learning in a Mouse Model of Neurodevelopmental Disorders
Published on: May 12, 2015